The potential role of bacteria in pancreatic cancer: a systematic review

被引:20
作者
Li, Ping [1 ]
Shu, Yongqian [1 ]
Gu, Yanhong [1 ]
机构
[1] Nanjing Med Univ, Dept Oncol, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China
关键词
HELICOBACTER-PYLORI INFECTION; ABO BLOOD-GROUP; PERIODONTAL-DISEASE; HEALTH-PROFESSIONALS; ORAL MICROBIOTA; GUT MICROBIOTA; RISK; ASSOCIATION; OBESITY; SEROPOSITIVITY;
D O I
10.1093/carcin/bgaa013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pancreatic cancer is a lethal and devastating disease in the worldwide. Recognized risk factors for pancreatic cancer include cigarette smoking, obesity, type II diabetes and chronic pancreatitis. Other factors such as variant ABO blood type and Helicobacter pylori may also play an important role in pancreatic carcinogenesis. Recently, growing evidence suggests that the association between bacteria and pancreatic cancer is positive and related immune/inflammation activation and increased nitrosamine exposure may be its potential mechanism. Interestingly, it is debatable whether the relationship of bacteria and pancreatic cancer is causative, reactive or parallel and future studies are in progress. Here we review recent progress in pancreatic cancer and its related bacteria.
引用
收藏
页码:397 / 404
页数:8
相关论文
共 79 条
[51]   Association between Helicobacter pylori infection and pancreatic cancer [J].
Raderer, M ;
Wrba, F ;
Kornek, G ;
Maca, T ;
Koller, DY ;
Weinlaender, G ;
Hejna, M ;
Scheithauer, W .
ONCOLOGY, 1998, 55 (01) :16-19
[52]   Toll-like receptors and cancer [J].
Rakoff-Nahoum, Seth ;
Medzhitov, Ruslan .
NATURE REVIEWS CANCER, 2009, 9 (01) :57-63
[53]   Gut microbial profile analysis by MiSeq sequencing of pancreatic carcinoma patients in China [J].
Ren, Zhigang ;
Jiang, Jianwen ;
Xie, Haiyang ;
Li, Ang ;
Lu, Haifeng ;
Xu, Shaoyan ;
Zhou, Lin ;
Zhang, Hua ;
Cui, Guangying ;
Chen, Xinhua ;
Liu, Yuanxing ;
Wu, Liming ;
Qin, Nan ;
Sun, Ranran ;
Wang, Wei ;
Li, Lanjuan ;
Wang, Weilin ;
Zheng, Shusen .
ONCOTARGET, 2017, 8 (56) :95176-95191
[54]   Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes [J].
Riquelme, Erick ;
Zhang, Yu ;
Zhang, Liangliang ;
Montiel, Maria ;
Zoltan, Michelle ;
Dong, Wenli ;
Quesada, Pompeyo ;
Sahin, Ismet ;
Chandra, Vidhi ;
San Lucas, Anthony ;
Scheet, Paul ;
Xu, Hanwen ;
Hanash, Samir M. ;
Feng, Lei ;
Burks, Jared K. ;
Do, Kim-Anh ;
Peterson, Christine B. ;
Nejman, Deborah ;
Tzeng, Ching-Wei D. ;
Kim, Michael P. ;
Sears, Cynthia L. ;
Ajami, Nadim ;
Petrosino, Joseph ;
Wood, Laura D. ;
Maitra, Anirban ;
Straussman, Ravid ;
Katz, Matthew ;
White, James Robert ;
Jenq, Robert ;
Wargo, Jennifer ;
McAllister, Florencia .
CELL, 2019, 178 (04) :795-+
[55]   Helicobacter pylori Seropositivities and Risk of Pancreatic Carcinoma [J].
Risch, Harvey A. ;
Lu, Lingeng ;
Kidd, Mark S. ;
Wang, Jing ;
Zhang, Wei ;
Ni, Quanxing ;
Gao, Yu-Tang ;
Yu, Herbert .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (01) :172-178
[56]   ABO Blood Group, Helicobacter pylori Seropositivity, and risk of Pancreatic Cancer: A Case-Control Study [J].
Risch, Harvey A. ;
Yu, Herbert ;
Lu, Lingeng ;
Kidd, Mark S. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (07) :502-505
[57]   MICROBIAL ECOLOGY OF GASTROINTESTINAL-TRACT [J].
SAVAGE, DC .
ANNUAL REVIEW OF MICROBIOLOGY, 1977, 31 :107-133
[58]   Gut Microbiota Promotes Tumor Growth in Mice by Modulating Immune Response [J].
Sethi, Vrishketan ;
Kurtom, Saba ;
Tarique, Mohammad ;
Lavania, Shweta ;
Malchiodi, Zoe ;
Hellmund, Leonor ;
Zhang, Li ;
Sharma, Umakant ;
Giri, Bhuwan ;
Garg, Bharti ;
Ferrantella, Anthony ;
Vickers, Selwyn M. ;
Banerjee, Sulagna ;
Dawra, Rajinder ;
Roy, Sabita ;
Ramakrishnan, Sundaram ;
Saluja, Ashok ;
Dudeja, Vikas .
GASTROENTEROLOGY, 2018, 155 (01) :33-+
[59]  
Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI [10.3322/caac.21442, 10.3322/caac.21551]
[60]   Helicobacter pylori seropositivity as a risk factor for pancreatic cancer [J].
Stolzenberg-Solomon, RZ ;
Blaser, MJ ;
Limburg, PJ ;
Perez-Perez, G ;
Taylor, PR ;
Virtamo, J ;
Albanes, D .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (12) :937-941